<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref041">
 <label>41</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>McIlleron</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Abdel-Rahman</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Dave</surname>
   <given-names>JA</given-names>
  </name>, 
  <name>
   <surname>Blockman</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Owen</surname>
   <given-names>A</given-names>
  </name>. 
  <article-title>Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research</article-title>. 
  <source>J Infect Dis</source>. 
  <year>2015</year>;
  <volume>211</volume>
  <issue>Suppl 3</issue>:
  <fpage>S115</fpage>â€“
  <lpage>25</lpage>. Epub 2015/05/27. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiu600</pub-id>
  <?supplied-pmid 26009615?>
  <pub-id pub-id-type="pmid">26009615</pub-id>
 </mixed-citation>
</ref>
